Navigation Links
Innovia Receives FDA Clearance For The InnoPort(TM)
Date:6/2/2009

New medical device will facilitate single port access laparoscopic surgery

MIAMI, June 2 /PRNewswire/ -- Innovia LLC, a privately held biomaterials-based medical device company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the InnoPort(TM) to facilitate single port access laparoscopy.

The InnoPort is inserted into the abdomen to perform laparoscopic surgery through one small incision--instead of multiple incisions--with the goal of minimizing scarring, pain, recovery time, and complication risk to the patient. The port is enabled by Quatromer(R), one of Innovia's proprietary biopolymers. The biopolymer's patented flexibility grants the physician unrestricted access to the abdominal cavity with up to three rigid and/or articulating instruments.

"In the time-sensitive and no-nonsense environment of the OR, the bell-and-whistle features of existing ports were overly complicated and tended to slow down my procedures. I needed a port that was simple and reliable, and this was the inspiration for the InnoPort," said David Edelman, MD, General Surgeon and inventor of the device. "Compared to other available single access ports, the InnoPort seems to be the easiest to use. The one-piece, stopper-shaped device can be inserted quickly, and its flexibility allows me to manipulate my instruments to extreme angulations without crowding one another in the working space, all while maintaining a tight insufflation seal."

"Our staff is especially proud to have worked with Dr. Edelman to develop the InnoPort," adds Len Pinchuk, Ph.D., D.Sc., President/CEO of Innovia. "We believe that the device will fulfill unmet clinical needs for simplicity and efficacy in the rapidly expanding single incision laparoscopic space and are confident that physicians will agree."

The InnoPort is scheduled for commercialization in the United States this year with expansion to Europe thereafter. For further information, please contact Innovia.

ABOUT INNOVIA LLC

Innovia is a privately held biomaterials-based medical device company that specializes in the development of innovative medical devices incorporating proprietary novel biomaterials. Innovia's experienced and highly specialized engineers, scientists, and chemists have been responsible for over $15 billion in revenue throughout their careers in the medical device industry. Please visit www.innovia-llc.com to learn more about the Company.


'/>"/>
SOURCE Innovia LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM)
2. Respected Surgeon Receives Emmy Nomination
3. Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators (ACATA)
4. LA BioMed researcher receives clinical teaching award
5. SAFC Pharmas St. Louis HPAPI Conjugates Facility Receives SafeBridge Certification
6. ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer
7. Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (Pink Eye)
8. Family Health International Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research Project Led by David Sokal, M.D.
9. Dalcon Receives Unified Communications Magazines Product of the Year Award
10. InfuSystem Receives Accreditation from the Community Health Accreditation Program (CHAP)
11. Childrens Health Fund Receives $500,000 from the Starr International Foundation to Support South Bronx Homeless Health Care Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... 2017 , ... A global center of excellence specializing in ... of the art center will provide advanced surgical care (heart surgery), management of ... patients longer lives. , North American Veterinary Heart Center, the “Heart Center,” will ...
(Date:7/26/2017)... ... July 26, 2017 , ... BioPlus Specialty Pharmacy ... version of the HCV Treatment Path app (version 4.4.0) to keep health care ... infection. All of the latest HCV medications are included in this app, including ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... of their partnership to provide the Pharmacist eCare Plan to Computer-Rx ... the country with the ability to develop the Pharmacist eCare Plan, a shared ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. ... Dr. Negrette has more than a decade of experience in psychiatry, treating clients ... individuals fighting addictions, eating disorders, psychotic and manic conditions, as well as those ...
(Date:7/24/2017)... , ... July 24, 2017 ... ... Director,      (407) 916-7235, kklaproth(at)robinsmorton(dot)com , Robins & Morton, Perkins ... to celebrate the structural topping out of the new Destination Medical Building ...
Breaking Medicine News(10 mins):
(Date:7/19/2017)... , July 19, 2017  Mako Medical Laboratories partnered ... the Military Family Assistance Fund (MFA) to bring 140 ... to visit with their families one last time before ... coordinate the travel and logistics needed for these soldiers. ... soldiers and their families. We just wish we could ...
(Date:7/14/2017)... VEGAS , July 13, 2017 It should ... United States is in the midst of a ... Control , since 1999, the number of overdose deaths from ... "resulting in over half a million dead from 2001 to ... codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a compelling ...
(Date:7/12/2017)... 12, 2017 CarpalAID is a revolutionary new product that ... Carpal tunnel syndrome affects more than 8 million people ... rate of men. The common methods of treating CTS are painful ... hand braces or gloves. ... CarpalAID is a clear patch worn on the ...
Breaking Medicine Technology: